BackInstil Bio Overview

Instil Bio Current Cash

Track Instil Bio's current cash ($5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$5.02M

Peer average

Loading

Instil Bio Current Cash History

Loading

Instil Bio vs. peers: Current Cash Comparison

Loading

Instil Bio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Instil Bio (TIL) FAQ

Instil Bio (TIL) currently reports a current cash of $5M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Instil Bio's current cash history and peer comparisons.

Instil Bio's current cash changed from $0 to $5M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Instil Bio reported $5M in current cash as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Instil Bio, and consider following TIL for alerts when major investors trade the stock.

Instil Bio is classified in the Healthcare sector. On current cash, it currently shows $5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TIL with unrelated industries.